These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4232287)
1. Erythrodermic psoriasis in childhood. A young Negro child treated with methotrexate. Scott RB; Surana R Am J Dis Child; 1968 Aug; 116(2):218-21. PubMed ID: 4232287 [No Abstract] [Full Text] [Related]
2. Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin. Si X; Ge L; Xin H; Cao W; Sun X; Li W Diagn Pathol; 2014 May; 9():102. PubMed ID: 24885087 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate]. Allegue Rodriguez F; Sendagorta Gomendio E; Freire Murgueytio P; Moreno Izquierdo R; Ledo Pozueta A Med Cutan Ibero Lat Am; 1988; 16(1):43-9. PubMed ID: 2967409 [TBL] [Abstract][Full Text] [Related]
5. Refractory erythrodermic psoriasis in a child with an excellent outcome by using etanercept. Fraga NA; Paim Mde F; Follador I; Ramos AN; Rêgo VR An Bras Dermatol; 2011; 86(4 Suppl 1):S144-7. PubMed ID: 22068796 [TBL] [Abstract][Full Text] [Related]
6. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis. Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805 [No Abstract] [Full Text] [Related]
7. Human low-dosage parenteral methotrexate therapy. A controlled toxicity study. Wright ET; Wolborsky M; Hamer EE Arch Dermatol; 1966 Jun; 93(6):731-6. PubMed ID: 4222659 [No Abstract] [Full Text] [Related]
8. [Erythrodermia, pustulal psoriasis, rheumatic state in a ten-year-old child. Successful effect of the combination of antibio-corticotherapy and methotrexate]. Huriez C; Desmons F; Struyve J Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):396-8. PubMed ID: 4251911 [No Abstract] [Full Text] [Related]
9. Life-threatening pustular and erythrodermic psoriasis responding to infliximab. Lewis TG; Tuchinda C; Lim HW; Wong HK J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis-induced postoperative cardiac failure. Jha PK; Das SR; Musleh GS; Lakshmanan S; Kingston TP; Deiraniya AK Ann Thorac Surg; 2005 Apr; 79(4):1390-1. PubMed ID: 15797087 [TBL] [Abstract][Full Text] [Related]
11. Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab. Rongioletti F; Borenstein M; Kirsner R; Kerdel F J Dermatolog Treat; 2003 Dec; 14(4):222-5. PubMed ID: 14660268 [TBL] [Abstract][Full Text] [Related]
12. [The use of methotrexate in dermatology. Indications and collateral effects]. Cerimele D Minerva Dermatol; 1967 Aug; 42(8):408-10. PubMed ID: 4237133 [No Abstract] [Full Text] [Related]
14. [Treatment of some forms of psoriasis with methotrexate]. Mazurkiewicz W; Miedzińska E Przegl Dermatol; 1970; 57(1):67-71. PubMed ID: 4244639 [No Abstract] [Full Text] [Related]
15. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission. Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816 [TBL] [Abstract][Full Text] [Related]
16. [Methotrexate therapy of dermatoses]. Leonhardi G; Erdemir M; Herrmann F Arch Klin Exp Dermatol; 1966; 227(1):363-71. PubMed ID: 4228527 [No Abstract] [Full Text] [Related]